
The majority of Directors of Investor Relations at BioReference Laboratories, Inc. believe they're not compensated fairly. The vast majority (79%) of Directors of Investor Relations at BioReference Laboratories, Inc. are satisfied with their benefits. See more compensation ratings at BioReference Laboratories, Inc.